biomarker

July 22, 2016July 22, 2016

Breast Cancer Gene Seen to Respond in Polar Ways, Either Promoting or Inhibiting Tumors

News

Researchers in Singapore have discovered how the gene EZH2, known to promote several types of cancer, is activated in breast cancer and lymphomas. Their findings, which may lead to new and more ... Read more

April 22, 2016October 18, 2016

Cartilage Protein Linked in Study to Aggressive, Metastatic Breast Cancer

News

A protein found mainly in cartilage tissue, called the Cartilage Oligomeric Matrix Protein (COMP), is present at high levels in patients with a poor breast cancer prognosis, and in animal studies contributed to ... Read more

June 30, 2015July 1, 2015

Inflammation May Promote Breast Cancer Spread

News

Inflammation is a normal bodily process that helps ward off disease and protect against infections. Following an injury, inflammation can help the body to recover. But if inflammation is chronic ... Read more

August 27, 2014October 18, 2016

Predicting Breast Cancer Outcomes May Improve, Thanks To Promising, New Biomarker

Breast Cancer News, News

A group of researchers from McGill University in Montreal, Canada, have discovered a new protein, p66ShcA, which could become a reliable biomarker to identify breast cancers with poor prognoses. One of ... Read more

August 21, 2014August 21, 2014

Biomarker Breakthrough In Basal-like Breast Cancer

Breast Cancer News, News

A biomarker associated with basal-like breast cancer, a highly aggressive carcinoma resistant to several types of chemotherapy, has been uncovered by researchers at Northwestern University, Illinois. Signal transducer and activator ... Read more

August 21, 2014October 18, 2016

Breast Cancer Relapse, Chemotherapy Effectiveness Can Now Be Determined By Gene

Breast Cancer News, News

A recent study entitled “DEAD-box helicase DP103 defines metastatic potential of human breast cancers” and published in the Journal of Clinical Investigation, identified a gene that can help to predict ... Read more

August 6, 2014August 6, 2014

PD-L1 Biomarker May Advance Immunotherapy Treatment For Early Stage Breast Cancer

Breast Cancer News, News

A newly developed molecular assay, PD-L1, was used to detect the levels of an important biomarker for immunotherapy in treating early stage breast cancers. Because the programmed death ligand/receptor1 (PD-1/PD-L1) axis ... Read more